Shopping Cart
- Remove All
- Your shopping cart is currently empty
Acrivastine (Acrivastin) is a short-acting histamine 1 receptor antagonist.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $31 | In Stock | |
10 mg | $47 | In Stock | |
25 mg | $100 | In Stock | |
50 mg | $163 | In Stock | |
100 mg | $233 | In Stock | |
500 mg | $583 | In Stock | |
1 g | $833 | In Stock | |
1 mL x 10 mM (in DMSO) | $34 | In Stock |
Description | Acrivastine (Acrivastin) is a short-acting histamine 1 receptor antagonist. |
In vivo | Acrivastine, administered typically at 8mg thrice daily, is a highly effective and well-tolerated antihistamine for managing chronic urticaria and allergic rhinitis, offering minimal drowsiness compared to clemastine and similar adverse effect profiles to placebo or terfenadine. It demonstrates superior efficacy over placebo and comparability to clemastine, hydroxyzine, chlorpheniramine, cyproheptadine, and terfenadine in treating histamine-related dermatoses. Both 4mg and 8mg doses notably improve symptoms of seasonal allergic rhinitis, including sneezing, runny nose, and overall discomfort, with the 8mg dose additionally reducing watery eyes and itchy throat symptoms. Therefore, acrivastine is recognized as both effective and well-tolerated in treating seasonal allergic rhinitis. |
Alias | Semprex, BW825C, Acrivastin |
Molecular Weight | 348.44 |
Formula | C22H24N2O2 |
Cas No. | 87848-99-5 |
Smiles | Cc1ccc(cc1)C(=C/CN1CCCC1)\c1cccc(\C=C\C(O)=O)n1 |
Relative Density. | 1.170 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 5 mg/mL (14.35 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.